1. Home
  2. TLS vs TOI Comparison

TLS vs TOI Comparison

Compare TLS & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$4.44

Market Cap

317.1M

Sector

Technology

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$3.43

Market Cap

304.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLS
TOI
Founded
1969
2007
Country
United States
United States
Employees
N/A
641
Industry
EDP Services
Medical/Nursing Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.1M
304.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
TLS
TOI
Price
$4.44
$3.43
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$7.90
$6.67
AVG Volume (30 Days)
680.8K
1.7M
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
31.51
N/A
EPS
N/A
N/A
Revenue
$164,805,000.00
N/A
Revenue This Year
$18.72
$30.15
Revenue Next Year
$14.62
$25.77
P/E Ratio
N/A
N/A
Revenue Growth
52.21
N/A
52 Week Low
$1.83
$1.91
52 Week High
$8.36
$4.88

Technical Indicators

Market Signals
Indicator
TLS
TOI
Relative Strength Index (RSI) 56.06 62.15
Support Level $3.80 $3.35
Resistance Level $4.61 $3.74
Average True Range (ATR) 0.20 0.21
MACD 0.02 0.02
Stochastic Oscillator 85.25 86.87

Price Performance

Historical Comparison
TLS
TOI

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: